Claire Poulet

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier et al. · European Journal of Cancer · 2020 · 72 citations

Medicine, Oncology, Pharmacology +12

Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series

Camille Taillé, Claire Poulet, S. Marchand‐Adam et al. · The Open Respiratory Medicine Journal · 2013 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors

L Gaucher, Leslie Adda, Alice Séjourné et al. · Therapeutic Advances in Medical Oncology · 2021 · 46 citations · Full text

Medicine, Oncology, Pharmacology +15

Impact of the corticosteroid indication and administration route on overall survival and the tumor response after immune checkpoint inhibitor initiation

L Gaucher, Leslie Adda, Alice Séjourné et al. · Therapeutic Advances in Medical Oncology · 2021 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): Results from the phase III study IFCT-1103 ULTIMATE.

Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier et al. · Journal of Clinical Oncology · 2016 · 24 citations

Medicine, Oncology, Pharmacology +13